Sometimes they come back: patent linkage for generic drugs reinstated
News | 19 November 2012
Within the space of a few months the Italian government has intervened twice on the sensitive issue of patent linkage for generic drugs, through two opposing decrees. In January 2012 Decree Law 1/2012, which was prompted by an EU infringement ...
Click on the link to read the full article at International Law Office
(This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
